Biopharma Firm Completes Reverse Stock Split

Biopharma Firm Completes Reverse Stock Split

Biopharma Firm Completes Reverse Stock Split By: Tomas Ronolski - AllPennyStocks.com News

Monday, July 31, 2023

Biopharmaceutical firm focused on the development and commercialization of innovative therapies, Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), announced in a press release that it has completed the previously announced consolidation of the issued and outstanding common shares of the Company’s share capital on the basis of one  post- consolidation share for each four pre-consolidation shares issued and outstanding, to regain compliance with NASDAQ listing requirements. The Consolidation received the applicable regulatory approvals, including from the Toronto Stock Exchange and the Nasdaq Stock Market. No shareholder approval was required for the Consolidation to come into effect. The Company’s common shares began trading on the TSX and the NASDAQ on a consolidated basis on July 31, 2023.

Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.  

Canadian shares finished Friday trade up, at $3.08.


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Industrial Safety Leader Announces Expansion Sending Shares Higher
Drill Less, Extract More: This Just Announced Merger Unlocks Profits
100,000,000 Euro Commitment Sends Shares of this MicroCap Hydrogen Automaker Soaring
Most Popular
FREE Newsletter


Back to Top